Lee Elvin Sanghwan 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-27 3:57 pm Purchase |
2023-10-23 | 13D | Salarius Pharmaceuticals, Inc. SLRX |
Lee Elvin Sanghwan | 25,534 6.090% |
25,534 (New Position) |
Filing |